The acquisition is already closed, so the focus shifts to integration and financial contribution. Monitor next quarter's earnings for initial revenue and margin accretion from Helvoet. The July 1 conference call may provide additional detail on synergy targets and updated guidance.
Price Chart
Executive Summary
Kimball Electronics acquired Helvoet Polymer Technologies B.V. and its Indian subsidiary for EUR 90 million (~$103M) in cash, funded from existing cash and credit lines. Helvoet is a medical CDMO with ~$56M revenue and mid-teens EBITDA margins, and the deal is expected to be accretive to fiscal 2027 adjusted earnings while expanding Kimball's medical CMO platform into Europe and India.
Key Financial Metrics
Key Facts
- Enterprise value of EUR 90 million (~$103 million) for Helvoet Polymer Technologies B.V. and Helvoet Rubber & Plastics Technologies (India) Pvt. Ltd.
- Helvoet generated ~$56 million in revenue in calendar 2025 with an EBITDA margin in the mid-teens.
- Transaction valued at approximately 9x estimated 2026 adjusted EBITDA.
- Acquisition funded with a combination of cash and existing lines of credit; ~$1.8 million held in escrow.
- Expected to be accretive to fiscal 2027 adjusted earnings and increase medical vertical sales in the low double-digit range.
- Acquisition closed on July 1, 2026; Helvoet leadership, including CEO Eveline Hogenkamp, remains in place.
Financial Impact
EUR 90M (~$103M) enterprise value, ~9x estimated 2026 EBITDA, expected to add low double-digit % to medical vertical sales and be accretive to FY2027 adjusted earnings
Risk Factors
- Integration risk combining operations across the U.S., Europe, and India.
- Potential increase in leverage from debt-funded portion of the deal.
- Execution of cross-border manufacturing and customer transitions.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001606757-26-000028 |
| Exhibit: ex991kimballelectronicsacq.htm | 0001606757-26-000028 |
| Document: ke-20260626.htm | 0001606757-26-000028 |
| Document: 0001606757-26-000028-index-headers.html | 0001606757-26-000028 |
| Document: 0001606757-26-000028-index.html | 0001606757-26-000028 |
| Document: 0001606757-26-000028.txt | 0001606757-26-000028 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 26d ago | DEFA14A | $27.33 | awaiting T+60 | — | $25.14 (−8.01%) |
Sep 30, 2026 26d ago | DEF 14A | $27.33 | awaiting T+60 | — | $25.14 (−8.01%) |
Jul 1, 2026 16w ago | 8-K | $25.71 $27.48 | ▲ +6.88% | ▲ +3.93% | $25.14 (−2.22%) |
May 5, 2026 24w ago | 8-K | $25.16 $24.73 | ▲ +1.71% | ▲ +3.77% | $25.14 (+0.08%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers